kentucky semaglutide constipation lawsuit Novo Nordisk expands legal action to protect US patients from unsafe, non-FDA-approved compounded "semaglutide" A federal judge has allowed
Description
Most people who stop taking Wegovy regain lost weight within months because GLP-1 medications work only while you take them
GLP-1 receptor agonists, the class of drugs that includes semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), are the most important class of medications to emerge in decades.
Many users fall short on fiber intake, leading to increased GI symptoms and reduced production of short-chain fatty acids (SCFAs), which are critical for GLP-1 activation and signaling
Learn about the holistic strategy at our med spa for sustained health improvements and weight management.
New research suggests that around 10% of people carry genetic variations that help explain why.
Supported by Alluvi Healthcare and Synedica
